Recurrent PIK3CA-E545K mutation promotes cervical cancer growth and invasion via AKT/mTOR signaling.
What this study shows
PIK3CA-E545K hotspot mutation enhances cervical cancer cell proliferation and invasion by activating AKT/mTOR signaling, validated in xenograft models.
At a glance
| Evidence type | M Molecular — cells, biochemistry, structure Marked M because it is molecular or in-vitro work (model: Human (cancer cell lines + xenograft)) rather than a whole-organism health-outcome study. That is often exactly where causal biology gets established -- the code says which system the finding was shown in, and nothing about how good the work is. |
| Study type | 5 - Mechanistic / In Vitro |
| Model system | Human (cancer cell lines + xenograft) |
| Journal | Molecular genetics and genomics |
| Year | 2026 |
| Peer reviewed | Yes |
| Record last updated | 2026-10-01 |
| Source | DOI 10.1007/s00438-026-02495-z · PMID 42562966 |
Extracted findings
These fields were extracted from the paper with AI assistance and have not been checked against the source. Read them as a pointer into the paper, not as curated claims; where they disagree with the curated summary above, the curated summary stands.
| Intervention | PIK3CA-E545K mutation |
| Target | AKT/mTOR |
| Model | Human |
| Effect | Promotes tumor cell proliferation and invasion |
In the Atlas
Related topics
Was this page useful?
Thank you. Your answer was counted anonymously.